CYP2R1 and myeloid sarcoma: In this evaluation, it was observed that the GG genotype of the CYP2R1 (SNP rs12794714) polymorphism was associated with the risk of MS (OR = 2.74, 95% CI = 1.14–6.58, p = 0.024).